Structural Biology in Drug Discovery

Structural biology plays a pivotal role in rational drug design and therapeutic development. High-resolution structural data enable identification of active sites, binding pockets, and molecular interactions critical for target modulation. Structure-based drug discovery integrates crystallography, cryo-EM, NMR, and computational docking to optimize lead compounds. Fragment-based screening approaches facilitate identification of promising drug candidates. Structural insights support the development of selective inhibitors with improved efficacy and reduced toxicity. Understanding resistance mechanisms at the molecular level informs next-generation therapeutic strategies. Integration of structural data with pharmacological studies accelerates translational research. Advances in precision medicine increasingly rely on detailed structural knowledge to design targeted therapies for complex diseases.

 

    Related Conference of Structural Biology in Drug Discovery

    July 23-24, 2026

    22nd World Congress on Structural Biology

    Aix-en-Provence, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Paris, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    Barcelona, Spain

    Structural Biology in Drug Discovery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in